Case Study: a Fortune 1000 pharmaceutical company strengthens security with Fidelis Deception

Fortune 1000 Pharmaceutical Company Tightens Security with Fidelis Deception

A Fortune 1000 pharmaceutical company was challenged with protecting its highly sensitive intellectual property and research assets from cyber attacks, in compliance with strict FDA and DEA regulations. The company needed to move beyond prevention and find a solution capable of accurately detecting advanced malware infections and unauthorized access attempts across its extensive network. They selected the Fidelis Deception platform from Fidelis Security to address these challenges.

Fidelis Security deployed its intelligent deception solution, which uses automated decoys to lure and expose attackers while providing comprehensive visibility into network traffic and communication channels. This provided the company with accurate, actionable alerts, eliminating the need to sort through false positives. As a result, the security team gained critical insight into potential threats and can now detect advanced persistent and zero-day attacks in progress, with the head of security stating the solution has "changed the rules of the game" against attackers.